<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>ONE TOUCH ADVANCED TOPICAL ANESTHETIC STRAWBERRY ICE- benzocaine, butamben and tetracaine hydrochloride gel </strong><br>HAGER WORLDWIDE, INC.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<span class="Bold">OneTouch<br>Advanced<br><br>Topical Anesthetic Gel                                                                                                                                                                                                                    Rx </span>Only<br><a name="ic85e331c-c5dd-42c1-81bc-f98b291e57ea"></a><table width="100%"><tbody class="Headless">
<tr class="First">
<td><span class="Bold">Active Ingredients:</span></td>
<td><br></td>
</tr>
<tr>
<td>Benzocaine<br>
</td>
<td>14.0%<br>
</td>
</tr>
<tr>
<td>Butamben<br>
</td>
<td>2.0%<br>
</td>
</tr>
<tr class="Last">
<td>Tetracaine Hydrochloride<br>
</td>
<td>2.0%<br>
</td>
</tr>
</tbody></table>
</div>
<div class="Section" data-sectionCode="51727-6">
<a name="section-2"></a><p></p>
<span class="Bold">Inactive Ingredients:</span><a name="i75144528-a5f8-4342-8323-1efe73aa527a"></a><table width="100%"><tbody class="Headless">
<tr class="First">
<td>Benzalkonium chloride<br>
</td>
<td>0.5%<br>
</td>
</tr>
<tr>
<td>Cetyl Dimethyl Ethyl Ammonium Bromide<br>
</td>
<td>0.005%<br>
</td>
</tr>
<tr class="Last">
<td>In bland, water-soluble base.<br>
</td>
<td><br></td>
</tr>
</tbody></table>
</div>
<div class="Section" data-sectionCode="43679-0">
<a name="section-3"></a><p></p>
<span class="Bold">Action</span><br>The onset of OneTouch Advanced-produced anesthesia is rapid (approximately<br>30 seconds) and the duration of anesthesia is typically 30-60 minutes, when<br>used as directed. This effect is due to the rapid onset, but short duration of<br>action of Benzocaine coupled with the slow onset, but extended duration of<br>Tetracaine HCI and bridged by the intermediate action of Butamben.<br><br>It is believed that all of these agents act by reversibly blocking nerve conduc-­<br>tion. Speed and duration of action is determined by the ability of the agent to<br>be absorbed by the mucous membrane and nerve sheath and then to diffuse<br>out, and ultimately be metabolized (primarily by plasma <span class="product-label-link" type="condition" conceptid="4052720" conceptname="Acetylcholinesterase">cholinesterases</span>) to inert<br>metabolites which are excreted in the urine.</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<p class="First"><span class="Bold">Indications </span><br>OneTouch Advanced Gel is a topical anesthetic indicated for the production<br>of anesthesia of all accessible mucous membrane except the eyes. OneTouch<br>Advanced Gel is indicated for use to control <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> in the mouth.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-5"></a><p></p>
<p class="First"><span class="Bold">Dosage and Administration </span><br>Only a limited quantity is OneTouch Advanced Gel is required for anesthesia.<br><br>Dispense 200 mg of gel (a bead approximately 1/4 to 1/2 inches long) by gently<br>depressing the pump.  Dispensing a bead of gel in excess of 400 mg is contrain-­<br>dicated. Spread thinly and evenly over the desired area using a cotton swab.<br><br>An appropriate pediatric dosage has not been established for OneTouch Ad-­<br>vanced Gel.<br><br>Dosages should be reduced in the debilitated elderly, acutely ill, and very young<br>patients.<br><br>Tissue need not be dried prior to application of OneTouch Advanced Gel. One-<br>Touch Advanced Gel should be applied directly to the site where <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> control is<br>required. Anesthesia is produced within one minute with an approximate duration<br>of thirty minutes. Each 200 mg dose of OneTouch Advanced Gel contains 28 mg<br>of benzocaine, 4 mg of butamben and 4 mg of tetracaine HCI.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-6"></a><p></p>
<span class="Bold">Adverse Reactions <br><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity Reactions</span>:</span> Unpredictable adverse reactions (i.e. hypersensi-­<br>tivity, including <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>) are extremely rare.<br><br>Localized <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> may occur after prolonged or repeated use of any<br>aminobenzoate anesthetic. The most common adverse reaction caused by<br>local anesthetics is <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span> characterized by <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> and <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span><br>that may progress to vesiculation and oozing. This occurs most commonly in<br>patients following prolonged self-medication, which is contraindicated. If <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>,<br><span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, or other manifestations of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> develop during use, the drug<br>should be discontinued. To minimize the possibility of a serious <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reaction</span>,<br>OneTouch Advanced Gel should not be applied for <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span> except<br>under continual supervision. <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">Dehydration</span> of the epithelium or an escharotic ef-­<br>fect may also result from prolonged contact.</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<p class="First"><span class="Bold">Precaution:</span> On rare occasions, <span class="product-label-link" type="condition" conceptid="432882" conceptname="Methemoglobinemia">methemoglobinemia</span> has been reported in<br>connection with the use of benzocaine-containing products. Care should be<br>used not to exceed the maximum recommended dosage (see Dosage and<br>Administration). If a patient becomes cyanotic, treat appropriately to counteract<br>(such as with methylene blue, if medically indicated).</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8"></a><p></p>
<span class="Bold">Use in Pregnancy: </span>Safe use of One Touch Advanced Gel has not been<br>established with respect to possible adverse effects upon fetal development.<br>Therefore, OneTouch Advanced Gel should not be used during early pregnancy,<br>unless in the judgement of a physician, the potential benefits outweigh the un-­<br>known hazards. Routine precaution for the use of any topical anesthetic should<br>be observed when OneTouch Advanced Gel is used.</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-9"></a><p></p>
<p class="First"><span class="Bold">Contraindications </span><br>OneTouch Advanced Gel is not suitable and should never be used for injection.<br>Do not use on the eyes. To avoid excessive systemic absorption, OneTouch<br>Advanced Gel should not be applied to large areas of denuded or inflamed<br>tissue. OneTouch Advanced Gel should not be administered to patients who are<br>hypersensitive to any of its ingredients or to patients known to have cholinest-­<br>erase deficiencies. Tolerance may vary with status of the patient.<br> <br>OneTouch Advanced Gel should not be used under dentures or cotton rolls, as<br>retention of the active gel ingredients under a denture or cotton roll could pos-­<br>sibly cause an escharotic effect. Routine precaution for the use of any topical<br>anesthetic should be observed when using OneTouch Advanced Gel. <br></p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<p class="First"><span class="Bold">How-Supplied </span><br>OneTouch Advanced Gel, 32 g jar</p>
<a name="i71b18fe7-f36e-46e9-8c15-cd7674aedcfd"></a><table width="100%"><tbody class="Headless">
<tr class="First">
<td>Cool Mint<br>
</td>
<td>NDC 62565-901-01<br>
</td>
</tr>
<tr>
<td>Strawberry Ice<br>
</td>
<td>NDC 62565-902-01<br>
</td>
</tr>
<tr>
<td>Bubble Gum<br>
</td>
<td>NDC 62565-903-01<br>
</td>
</tr>
<tr class="Last">
<td>Cherry<br>
</td>
<td>NDC 62565-904-01<br>
</td>
</tr>
</tbody></table>Manufactured for<br><span class="Bold">HAGER<br>WORLDWIDE</span><br>13322 Byrd Drive<br>Odessa, FL 33556 USA<br><br>Made in U.S.A.        Rev. 6/09 <br><p></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<a name="i709b9749-d65c-4f4c-87dc-33b95ce82818"></a><table width="100%"><tbody class="Headless"><tr class="First Last">
<td>
<span class="Bold">Caution: Rx Only.</span><br>Do not use in eyes.  Keep out of reach of children.<br><br><span class="Bold">Directions:</span> Read package insert.<br>Press top of container to dispense desired amount.<br>Dispense 200 mg of gel (a bead approximately<br>1/4 to 1/2 inches long) by gently depressing the<br>pump.  Dispensing a bead in excess of 400 mg is<br>contraindicated.  Spread thinly and evenly over the<br>desired area using a cotton swab.<br><br><span class="Bold">Active Ingredients: </span>Benzocaine 14.0%,<br>Butamben 2.0%, Tetracaine Hydrochloride 2.0%<br><span class="Bold">Inactive Ingredients:</span> Benzalkonium Chloride<br>0.5%, Cetyl Dimethyl Ethyl Ammonium Bromide<br>0.005%, in a bland water-soluble base.<br>
</td>
<td>NDC 62565-902-01<br><span class="Bold">OneTouch<br>Advanced<br><br><br>Topical Anesthetic Gel</span><br>OneTouch Advanced<br>is indicated for anesthesia of<br>accessible mucous membrane.<br><br><br><span class="Bold">Strawberry Ice</span><br>Net Wt. 32 g<br><br><br>Store in a cool dry place.<br>
</td>
<td>
<br><br><br><br><br>Manufactured for:<br><span class="Bold">HAGER</span><br><span class="Bold">WORLDWIDE<br></span>Odessa, FL  33556 USA<br><br><br>Item #6256590201<br><br><br><br>Made in U.S.A.   Rev. 05/09<br>
</td>
</tr></tbody></table>
<div class="Figure"><img alt="Image of principal jar label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a75b6e20-a180-4a8d-be08-de54812c4f5e&amp;name=jarlabelsi.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ONE TOUCH ADVANCED TOPICAL ANESTHETIC 		
					STRAWBERRY ICE</strong><br><span class="contentTableReg">benzocaine, butamben, tetracaine hydrochloride gel</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:62565-902</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL, DENTAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>BENZOCAINE</strong> (BENZOCAINE) </td>
<td class="formItem">BENZOCAINE</td>
<td class="formItem">28 mg  in .2 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>BUTAMBEN</strong> (BUTAMBEN) </td>
<td class="formItem">BUTAMBEN</td>
<td class="formItem">4 mg  in .2 g</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TETRACAINE HYDROCHLORIDE</strong> (TETRACAINE) </td>
<td class="formItem">TETRACAINE HYDROCHLORIDE</td>
<td class="formItem">4 mg  in .2 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZALKONIUM CHLORIDE</strong></td>
<td class="formItem">1 mg  in .2 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">orange (ORANGE) </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">STRAWBERRY (STRAWBERRY ICE) </td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:62565-902-01</td>
<td class="formItem">1  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">32 g in 1 JAR</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">02/01/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>HAGER WORLDWIDE, INC.
							(009277971)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>HAGER WORLDWIDE, INC. (009277971)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">HAGER WORLDWIDE, INC.</td>
<td class="formItem"></td>
<td class="formItem">009277971</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 11/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>69f13372-d95d-4dbc-ae03-ed9a0b49592a</div>
<div>Set id: a75b6e20-a180-4a8d-be08-de54812c4f5e</div>
<div>Version: 1</div>
<div>Effective Time: 20111123</div>
</div>
</div> <div class="DistributorName">HAGER WORLDWIDE, INC.</div></p>
</body></html>
